Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03588481 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IRIS- DESyne X2 in the IRIS-DES Registry

Study acronym: IRIS DESyne X2
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Study completion pushed from Dec 31, 2030 to Dec 31, 2031
    • Site details revised at 1 of 6 sites
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Primary completion date: Dec 31, 2024 to Dec 31, 2026
    • Study completion date: Dec 31, 2028 to Dec 31, 2030
    • Secondary endpoints: details revised at 1 of 10 entries
    v7
  4. Site details revised at 2 of 6 sitesv6
  5. Primary completion date: Dec 31, 2022 to Dec 31, 2024
    • Study completion date: Dec 31, 2026 to Dec 31, 2028
    • Site contacts updated at 5 of 6 sites
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Secondary endpoints: 9 to 10v4
  2. Primary completion date: Dec 31, 2020 to Dec 31, 2022
    • Study sites: 1 to 6
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 30, 2018 to Nov 28, 2018
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Seung-Jung Park
22 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Trial Details
NCT Number NCT03588481
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions
(from sponsor)		 Coronary Stenosis, Coronary Occlusion, Coronary Disease
Related terms Coronary Disease, Coronary Occlusion, Coronary Stenosis
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov